scholarly article | Q13442814 |
P356 | DOI | 10.1007/S11936-018-0621-3 |
P698 | PubMed publication ID | 29569013 |
P50 | author | Puja B Parikh | Q84872687 |
P2093 | author name string | Arash Ehteshami Afshar | |
P2860 | cites work | Importance of establishing radiation protection culture in Radiology Department | Q26765144 |
Risk prediction models for contrast induced nephropathy: systematic review | Q26796473 | ||
Contrast-Induced Acute Kidney Injury | Q28077950 | ||
Prophylaxis strategies for contrast-induced nephropathy | Q28247353 | ||
Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality | Q28247556 | ||
Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis | Q28272756 | ||
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation | Q28285964 | ||
Reducing contrast-induced acute kidney injury using a regional multicenter quality improvement intervention | Q28602648 | ||
Radiation dose reduction in the invasive cardiovascular laboratory: implementing a culture and philosophy of radiation safety | Q30420634 | ||
Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommen | Q33496413 | ||
Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis | Q33497692 | ||
Patient radiation doses in interventional cardiology procedures | Q33578019 | ||
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). | Q33753500 | ||
Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine | Q33910096 | ||
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry | Q34005294 | ||
Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). | Q34209991 | ||
On Contrast-Induced Acute Kidney Injury, Risk Prediction, and the Future of Predictive Model Development | Q48041313 | ||
Robotic-assisted percutaneous coronary intervention | Q48103286 | ||
Use of the RenalGuard system to prevent contrast-induced AKI: A meta-analysis | Q48132610 | ||
Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures | Q48307298 | ||
Current Risk of Contrast-Induced Acute Kidney Injury After Coronary Angiography and Intervention: A Reappraisal of the Literature | Q49894492 | ||
A Practical Approach to Radiation Protection for Cardiac Catheterization Laboratory Staff | Q50162199 | ||
Impact of a lead glass screen on scatter radiation to eyes and hands in interventional cardiologists. | Q50772074 | ||
Effectiveness of low rate fluoroscopy at reducing operator and patient radiation dose during transradial coronary angiography and interventions. | Q53570789 | ||
Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease. | Q53729984 | ||
Subclinical carotid atherosclerosis and early vascular aging from long-term low-dose ionizing radiation exposure: a genetic, telomere, and vascular ultrasound study in cardiac catheterization laboratory staff. | Q54165061 | ||
Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography-pulmonary angiography | Q57561042 | ||
Risk for radiation-induced cataract for staff in interventional cardiology: Is there reason for concern? | Q61650648 | ||
Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media | Q70184898 | ||
Using a sterile disposable protective surgical drape for reduction of radiation exposure to interventionalists | Q77386896 | ||
A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity | Q78461798 | ||
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies | Q79798558 | ||
Somatic DNA damage in interventional cardiologists: a case-control study | Q81599842 | ||
Chronic kidney injury in patients after cardiac catheterisation or percutaneous coronary intervention: a comparison of radial and femoral approaches (from the British Columbia Cardiac and Renal Registries) | Q84611100 | ||
Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study | Q85003450 | ||
Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: a single-center, randomized trial | Q85798622 | ||
Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention | Q86902402 | ||
Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials | Q34486268 | ||
Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy | Q34613433 | ||
Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis | Q35910056 | ||
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures | Q35954734 | ||
Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD | Q36025621 | ||
Pathophysiology of contrast medium-induced nephropathy. | Q36162405 | ||
N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best? | Q36277926 | ||
Contrast medium use. | Q36584089 | ||
Prevention of contrast-induced nephropathy: a critical review. | Q36848113 | ||
Contrast-induced nephropathy: what are the true clinical consequences? | Q37051997 | ||
Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis | Q37362282 | ||
Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography | Q37991688 | ||
Recommendations for occupational radiation protection in interventional cardiology | Q38087941 | ||
A Review of the Use of Iloprost, A Synthetic Prostacyclin, in the Prevention of Radiocontrast Nephropathy in Patients Undergoing Coronary Angiography and Intervention. | Q38473542 | ||
Optimizing Radiation Safety in the Cardiac Catheterization Laboratory: A Practical Approach. | Q38622800 | ||
Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis | Q38623589 | ||
Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy : a systematic review and meta-analysis | Q38645734 | ||
Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: A systematic review and trial sequential analysis | Q38706984 | ||
Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis | Q38972985 | ||
Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies. | Q39392457 | ||
Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials | Q39418338 | ||
Changing patterns of atheroembolism | Q39435216 | ||
A randomized study comparing the use of a pelvic lead shield during trans-radial interventions: Threefold decrease in radiation to the operator but double exposure to the patient | Q40243870 | ||
Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography | Q40294818 | ||
Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial | Q40320681 | ||
Estimating the Risk of Radiocontrast-Associated Nephropathy | Q40559288 | ||
Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. | Q43258600 | ||
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial | Q43482729 | ||
Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure | Q43975017 | ||
Acetylcysteine and contrast agent-associated nephrotoxicity | Q44054777 | ||
Postischemic acute renal failure is reduced by short-term statin treatment in a rat model | Q44111644 | ||
Determinants of serum creatinine trajectory in acute contrast nephropathy | Q44221725 | ||
Effectiveness of a lead cap in radiation protection of the head in the cardiac catheterisation laboratory | Q44484198 | ||
A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study | Q44487840 | ||
Efficacy of the RADPAD protective drape during real world complex percutaneous coronary intervention procedures | Q44535659 | ||
Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. | Q45942188 | ||
Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity | Q46468399 | ||
Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions | Q47153010 | ||
Impact of Transient or Persistent Contrast-induced Nephropathy on Long-term Mortality After Elective Percutaneous Coronary Intervention | Q47651860 | ||
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX. | Q47862169 | ||
P433 | issue | 4 | |
P921 | main subject | coronary angiography | Q1482382 |
radiation sickness | Q21652028 | ||
P304 | page(s) | 32 | |
P577 | publication date | 2018-03-22 | |
P1433 | published in | Current treatment options in cardiovascular medicine | Q27714743 |
P1476 | title | Prevention of Contrast and Radiation Injury During Coronary Angiography and Percutaneous Coronary Intervention | |
P478 | volume | 20 |
Search more.